News
London-based Peak has raised $7 million for its brain training app, in a round led by Creandum with participation from DN Capital, London Venture Partners, and Qualcomm Ventures.
Just a few days before the first units start shipping, Apple has posted some support documents that pull back the curtain on some of the technical details of its heart rate monitor, and also give some insight into steps Apple has taken to head off potential skin irritation issues.
While most clinicians carry one or more mobile devices for a variety of use cases, it's still the case that no single screen is as popular as the desktop computer for physicians, according to a new survey released by Microsoft.
New Jersey's Division of Consumer Affairs has launched a new app for iPhones that will allow authorized users of the state’s prescription monitoring program, prescribers and pharmacists licensed in New Jersey, access to the database via their smartphone.
Jawbone UP2
It's been a busy week for Jawbone.
Weight Watchers is recruiting for a randomized control trial that will test the addition of a connected scale into its online weight loss intervention, according to a posting on ClinicalTrials.
In a pilot that included more than 350 chronic heart failure patients, a Philadelphia hospital was able to reduce its 30-day readmissions by 10 percent -- a 40 percent improvement over baseline -- by using email and text message reminders to get patients into follow-up appointments.
At Boston Children's Hospital's second annual Innovator's Showcase this week, researchers and clinicians presented a number of new technology-focused offerings that are currently in use or being tested at the hospital.
Boston-based meQuilibrium, which has developed a mobile stress management program, raised $9 million in a funding round led by Safeguard Scientifics with participation from Chrysalis Ventures.
Boston-based patient network PatientsLikeMe announced two pieces of pharma news this week: a five-year research collaboration deal with AstraZeneca and the results of a multiple sclerosis wearable study conducted in collaboration with Biogen.